Iristectorigenin A(CAS: 39012-01-6)

CAS Number
Related Products
2',4-Dihydroxy-4',6'-dimethoxychalcone
CAS Number: 37308-75-1
2-(3,4-Dihydroxyphenyl)ethyl acetate
CAS Number: 69039-02-7
7-Fluorotryptophan
CAS Number: 138514-98-4
Andrographidine C
CAS Number: 113963-39-6
Other Suppliers for Iristectorigenin A
Basic Information
Molecular Formula
C17H14O7
Molecular Weight
330.29 g/mol
Physical Properties
Melting Point
237-238 ºC
Chemical Identifiers
SMILES
COC1=C(C=CC(=C1)C2=COC3=C(C2=O)C(=C(C(=C3)O)OC)O)O
InChIKey
CCRPIWFQMLICCY-UHFFFAOYSA-N
Database References
MDL Number
MFCD01662757
FAQ
Iristectorigenin A (CAS: 39012-01-6) falls under GHS classification as a hazardous substance, requiring appropriate labeling and safety data sheets (SDS). For synthesis and commercial use, it must comply with REACH regulations in the European Union, ensuring that manufacturers and importers register the substance if it is produced or imported at or above 1 ton per year. Additionally, FDA and EPA guidelines are relevant for the formulation and distribution of products containing this compound, focusing on safety and environmental protection.
Alternatives to iristectorigenin A (CAS: 39012-01-6) in synthesis include its analogs such as iristectorigenin B and C, which can be used based on the specific requirements of the reaction. Common alternative reagents include other terpenoids and flavonoids. Isomers of iristectorigenin A can also be used, but their properties and reactivity may differ. These alternatives should be carefully evaluated for their efficacy and compatibility with the target chemical process.
The market for iristectorigenin A (CAS: 39012-01-6) is growing due to its potential applications in natural product chemistry and medical research. Recent research trends focus on the biological activities of iristectorigenin A, such as its antioxidant and anti-inflammatory properties, which could lead to new drug candidates. Market demand is increasing as more studies explore its therapeutic potential, particularly in the treatment of diseases like cancer and neurodegenerative disorders.
Waste containing iristectorigenin A (CAS: 39012-01-6) should be collected in appropriate containers and stored separately from other waste materials. For disposal, it is recommended to incinerate the waste according to local regulations or use professional waste disposal services that follow environmental protection guidelines. Proper handling includes ensuring that all safety measures are in place to prevent leakage or spillage, and that all personnel are trained in the safe management of hazardous chemicals.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
2851167780@qq.com
Mobile
13348961525
Fax
028-81705658
Visit Website
https://www.weikeqi-biotech.com
![1-[4-Amino-3-chloro-5-(trifluoromethyl)phenyl]-2-[(2-methyl-2-propanyl)amino]ethanol hydrochloride (1:1)](https://static.chemtradehub.com/structs/542/54240-36-7-06e4.webp)


![8-({(3R,4R,5S)-3-[(4,4-Difluorocyclohexyl)methoxy]-5-methoxy-4-piperidinyl}amino)-3-methyl-5-(5-methyl-3-pyridinyl)-1,7-naphthyridin-2(1H)-one](https://static.chemtradehub.com/structs/199/1997369-78-4-ea15.webp)


![5-[(1S)-1-{(1R,2R)-2-[(1R,3R)-2,2-Dimethyl-3-(3-oxobutyl)cyclopropyl]-1-methyl-3-oxocyclopentyl}-3-methylbutyl]-2,4,6-trihydroxyisophthalaldehyde](https://static.chemtradehub.com/structs/221/221899-21-4-fc5c.webp)

![(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylethyl]acrylamide](https://static.chemtradehub.com/structs/857/857064-38-1-2c6b.webp)






